Response of endothelial cells to a dual tyrosine kinase receptor inhibition combined with irradiation

Molecular Cancer Therapeutics

Volumn 4, Issue 12, 2005, Pages 1962-1971

  Bozec, Alexandre ^a   Formento, Patricia ^a   Ciccolini, Joseph ^b   Fanciullino, Raphaëlle ^b   Padovani, Laetitia ^b   Murraciole, Xavier ^b   Fischel, Jean Louis ^a   Milano, Gerard ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; DNA DEPENDENT PROTEIN KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; FAS ANTIGEN; GEFITINIB; MOLECULAR MARKER; PROTEIN KINASE B; PROTEIN P42; PROTEIN P44; PROTEIN TYROSINE KINASE INHIBITOR; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR 2; ZM 317450;

ANALYSIS OF VARIANCE; ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RADIOTHERAPY; CELL GROWTH; CELL LINE; CONCENTRATION RESPONSE; CYTOTOXICITY; DRUG POTENTIATION; DRUG TARGETING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IRRADIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL DIVISION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; HUMANS; QUINAZOLINES; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 30344440398     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-05-0108     Document Type: Article

References (36)

1. Mendelsohn J, Baselga J. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J Clin Oncol 2003; 21:2787-99.
2. Arteaga C. Targeting HER1/EGFR: a molecular approach to cancer therapy. Semin Oncol 2003;30:3-14.
3. Grünwald V, Hidalgo M. Developing inhibitors of the epidermal growth factor receptor for cancer treatment. J Natl Cancer Inst 2003;95:851-67.
4. Magne N, Fischel JL, Tiffon C, et al. Molecular mechanisms underlying the interaction between gefitinib ("Iressa") and cisplatin/5-fluorouracil. Br J Cancer 2003;89:585-92.
5. Petty WJ, Dragnev KH, Memoli VA, et al. Epidermal growth factor receptor tyrosine kinase inhibition represses cyclin D1 in aerodigestive tract cancers. Clin Cancer Res 2004;10:7547-54.
6. Cip1 in growth inhibition mediated by blockade or overstimulation of epidermal growth factor receptors. Clin Cancer Res 1997;3:1943-8.
7. 1 arrest in oral squamous carcinoma cell lines. Oncology 2002; 63:92-8.
8. Kedar D, Baker CH, Killion JJ, Dinney CP, Fiedler IJ. Blockade of the epidermal growth factor receptor signaling inhibits angiogenesis leading to regression of human renal cell carcinoma growing orthotopically in nude mice. Clin Cancer Res 2002;8:3592-600.
9. Bruns CJ, Solorzano CC, Harbison MT, et al. Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma. Cancer Res 2000;60:2926-35.
10. Tortora G, Caputo R, Damiano V, et al. Combined targeted inhibition of bcl-2, bcl-XL, epidermal growth factor receptor, and protein kinase a type I causes potent antitumor, apoptotic, and antiangiogenic activity. Clin Cancer Res 2003;9:866-71.
11. Ciardiello F, Caputo R, Bianco R, et al. Inhibition of growth factor production and angiogenesis in human cancer cells by gefitinib (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. Clin Cancer Res 2001;7:1459-65.
12. Shaheen RM, Ahmad SA, Liu W, et al. Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors. Br J Cancer 2001;85:548-9.
13. Ciardiello F, Bianco R, Caputo R, et al. Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy. Clin Cancer Res 2004;10:784-93.
14. Yigitbasi OG, Younes MN, Doan D, et al. Tumor cell and endothelial cell therapy of oral cancer by dual tyrosine kinase receptor blockade. Cancer Res 2004;64:7977-84.
15. Hirata A, Ogawa S, Kometani T, et al. gefitinib (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase. Cancer Res 2002;62:2554-60.
16. Abdollahi A, Lipson KE, Han X, et al. SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro. Cancer Res 2003;63:3755-63.
17. O'Hare MJ, Bond J, Clarke C, et al. Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells. Proc Natl Acad Sci U S A 2001;98:646-51.
18. Gasmi A, Bourcier C, Aloui Z, et al. Complete structure of an increasing permeability protein (ICPP) purified from Vipera lebetina venom. J Biol Chem 2002;277:29992-8.
19. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987;47:936-42.
20. Chou T, Talalay P. Quantitative analysis of dose-effects relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984;22:27-55.
21. Raben D, Bianco C, Damiano V, et al. Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung xenograft model. Mol Cancer Ther 2004;3:977-83.
22. Ono M, Okamura K, Nakayama Y, et al. Induction of human microvascular endothelial tubular morphogenesis by human keratinocytes: involvement of transforming growth factor-α. Biochem Biophys Res Commun 1992;189:601-9.
23. Hirata A, Uehara H, Izumi K, Naito S, Kuwano M, Ono M. Direct inhibition of EGF receptor activation in vascular endothelial by gefitinib ("Iressa," ZD1839). Cancer Sci 2004;95:614-8.
24. Kallmann BA, Wagner S, Hummel V, et al. Characteristic gene expression profile of primary human cerebral endothelial cells. FASEB J 2002;16:589-91.
25. Chen K, Vita JA, Berk BC, Keaney JF, Jr. C-Jun N-terminal kinase activation by hydrogen peroxide in endothelial cells involves SRC-dependent epidermal growth factor receptor transactivation. J Biol Chem 2001;276:16045-50.
26. Hallahan DE, Virudachalam S, Sherman MA, Huberman E, Kufe DW, Weichselbaum RR. Tumor necrosis factor gene expression is mediated by protein kinase C following activation by ionizing irradiation. Cancer Res 1991;51:4565-9.
27. Hallahan DE, Sukatme VP, Sherman ML, Virudachalam S, Kufe DW. Protein kinase C mediates X-ray inducibility of nuclear signal transducers EGR1 and JUN. Proc Natl Acad Sci U S A 1991;88:2156-60.
28. Sherman ML, Datta R, Hallahan DE, Beckett MA, Weichselbaum RR, Kufe DW. Ionizing radiation regulates expression of the c-jun protooncogene. Proc Natl Acad Sci U S A 1990;87:5663-6.
29. Schmidt-Ullrich RK, Valerie K, Fogleman PB, Walters J. Radiation-induced autophosphorylation of epidermal growth factor receptor in human malignant mammary and squamous epithelial cells. Radiat Res 1996;145:81-5.
30. Sonveaux P, Brouet A, Havaux X, et al. Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy. Cancer Res 2003;63:1012-9.
31. Matsuura H, Sakaue M, Subbaramaiah K, et al. Regulation of cyclooxygenase-2 by interferon-γ and transforming growth factor α in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases. J Biol Chem 1999; 274:29138-48.
32. Garcia-Barros M, Paris F, Cordon-Carlo C, et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003;300:1155-9.
33. Puusaari I, Heikkonen J, Kivela T. Ocular complications after iodine brachytherapy for large uveal melanomas. Ophthalmology 2004;111: 1768-77.
34. Koukourakis MI, Giatromanolaki A, Sivridis E, et al. Squamous cell head and neck cancer: evidence of angiogenic regeneration during radiotherapy. Anticancer Res 2001;21:4301-9.
35. Williams KJ, Telfer BA, Brave S, et al. ZD6474, a potent inhibitor of vascular endothelial growth factor signaling, combined with radiotherapy: schedule-dependent enhancement of antitumor activity. Clin Cancer Res 2004;10:8587-93.
36. Friedmann B, Caplin M, Hartley JA, Hochlauser D. Modulation of DNA repair in vitro after treatment with chemotherapeutic agents by the epidermal growth factor receptor inhibitor gefitinib (ZD1839). Clin Cancer Res 2004;10:6476-86.